Buick R N, Fry S E, Salmon S E
Cancer. 1980 Mar 15;45(5 Suppl):1238-42. doi: 10.1002/1097-0142(19800315)45:5+<1238::aid-cncr2820451333>3.0.co;2-r.
An in vitro assay to measure the clonogenic or colony-forming capability of cancer cells present in biopsy samples has recently been applied to study the biology and drug-sensitivity of a variety of human neoplasms. This approach appears to be suitable for study of the tumor stem or progenitor cells present in malignant effusions from patients with colonic carcinoma. In our preliminary studies, morphology of the tumor colonies by inverted microscopy and with Papanicolaou staining of dried agar plating layers as well as immunofluorescent localization with a specific antiserum to human carcinoembrionic antigen have been used as markers of the neoplastic origin of colon tumor colony-forming cells. Successful application of this assay to colonic solid tumors will require improvement in techniques for disaggregation of viable clonogenic cells. We anticipate that short term clonal assays will have increasing use for clinical and biological studies of human colon cancer.
一种用于测量活检样本中癌细胞克隆形成或集落形成能力的体外试验,最近已被应用于研究多种人类肿瘤的生物学特性和药物敏感性。这种方法似乎适用于研究结肠癌患者恶性胸腔积液中存在的肿瘤干细胞或祖细胞。在我们的初步研究中,通过倒置显微镜观察肿瘤集落的形态、对干燥琼脂平板层进行巴氏染色以及使用针对人癌胚抗原的特异性抗血清进行免疫荧光定位,已被用作结肠肿瘤集落形成细胞肿瘤起源的标志物。要将该试验成功应用于结肠实体瘤,需要改进活克隆形成细胞的解离技术。我们预计,短期克隆试验在人类结肠癌的临床和生物学研究中将得到越来越多的应用。